GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk primary ...

Qiagen collaborates with McGill University to advance microbiome research: Montreal, Canada Thursday, November 14, 2024, 10:00 Hrs [IST] Qiagen, a Netherlands-based leading global ...

The Drugs Controller General of India (DCGI) will be meeting the stakeholders in the cosmetics industry in the country to discuss the issues relating to the regulatory provisions of the cosmetics ...

Peethaambaran Kunnathoor, Chennai Thursday, November 14, 2024, 08:00 Hrs [IST] ...

Pharma Programme, that the Pradhan Mantri Scholarship for Pharmacy Postgraduate Studies (PMSPPS) will be awarded to eligible ...

Pharmacy college job fairs propel rapport between academia and industry to create capable workforce: Nandita Vijayasimha, Bengaluru Thursday, November 14, 2024, 08:00 Hrs [IST] Ph ...

Our Bureau, Mumbai Wednesday, November 13, 2024, 12:15 Hrs [IST] ...

UDF proposes need for a centralized drug regulatory cadre, regulatory body in India to bolster patient safety: Shardul Nautiyal, Mumbai Thursday, November 14, 2024, 08:00 Hrs [IST ...

Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...

Aethlon Medical reaches key milestone with enrollment of first patient in its Hemopurifier cancer trial in Australia: San Diego Wednesday, November 13, 2024, 15:30 Hrs [IST] Aethl ...

Sonoma Pharma receives US FDA 510(k) clearance for Microcyn-based wound care hydrogel: Boulder, Colorado Wednesday, November 13, 2024, 16:00 Hrs [IST] Sonoma Pharmaceuticals, Inc.

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...